###begin article-title 0
###xml 49 65 49 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sleeping Beauty </italic>
###xml 35 40 <span type="species:ncbi:10090">mouse</span>
Conditional gene expression in the mouse using a Sleeping Beauty gene-trap transposon
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 128 136 128 136 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 139 150 139 150 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila </italic>
###xml 205 221 205 221 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sleeping Beauty </italic>
###xml 128 135 <span type="species:ncbi:110766|species:ncbi:562">E. coli</span>
###xml 139 149 <span type="species:ncbi:7227">Drosophila</span>
###xml 174 179 <span type="species:ncbi:10090">mouse</span>
###xml 322 327 <span type="species:ncbi:10090">mouse</span>
###xml 485 490 <span type="species:ncbi:10090">mouse</span>
###xml 603 608 <span type="species:ncbi:10090">mouse</span>
Insertional mutagenesis techniques with transposable elements have been popular among geneticists studying model organisms from E. coli to Drosophila and, more recently, the mouse. One such element is the Sleeping Beauty (SB) transposon that has been shown in several studies to be an effective insertional mutagen in the mouse germline. SB transposon vector studies have employed different functional elements and reporter molecules to disrupt and report the expression of endogenous mouse genes. We sought to generate a transposon system that would be capable of reporting the expression pattern of a mouse gene while allowing for conditional expression of a gene of interest in a tissue- or temporal-specific pattern.
###end p 3
###begin title 4
Results
###end title 4
###begin p 5
###xml 327 336 327 336 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 703 711 703 711 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 383 388 <span type="species:ncbi:9606">human</span>
###xml 528 543 <span type="species:ncbi:10090">transgenic mice</span>
Here we report the systematic development and testing of a transposon-based gene-trap system incorporating the doxycycline-repressible Tet-Off (tTA) system that is capable of activating the expression of genes under control of a Tet response element (TRE) promoter. We demonstrate that the gene trap system is fully functional in vitro by introducing the "gene-trap tTA" vector into human cells by transposition and identifying clones that activate expression of a TRE-luciferase transgene in a doxycycline-dependent manner. In transgenic mice, we mobilize gene-trap tTA vectors, discover parameters that can affect germline mobilization rates, and identify candidate gene insertions to demonstrate the in vivo functionality of the vector system. We further demonstrate that the gene-trap can act as a reporter of endogenous gene expression and it can be coupled with bioluminescent imaging to identify genes with tissue-specific expression patterns.
###end p 5
###begin title 6
Conclusion
###end title 6
###begin p 7
###xml 130 135 <span type="species:ncbi:10090">mouse</span>
###xml 317 322 <span type="species:ncbi:10090">mouse</span>
###xml 356 360 <span type="species:ncbi:10090">mice</span>
###xml 498 502 <span type="species:ncbi:10090">mice</span>
###xml 539 544 <span type="species:ncbi:10090">mouse</span>
Akin to the GAL4/UAS system used in the fly, we have made progress developing a tool for mutating and revealing the expression of mouse genes by generating the tTA transactivator in the presence of a secondary TRE-regulated reporter molecule. A vector like the gene-trap tTA could provide a means for both annotating mouse genes and creating a resource of mice that express a regulable transcription factor in temporally- and tissue-specific patterns for conditional gene expression studies. These mice would be a valuable resource to the mouse genetics community for purpose of dissecting mammalian gene function.
###end p 7
###begin title 8
Background
###end title 8
###begin p 9
###xml 46 47 46 47 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 54 70 54 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sleeping Beauty </italic>
###xml 109 117 109 117 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mariner </italic>
###xml 169 170 169 170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 232 233 232 233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 269 270 269 270 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 271 272 271 272 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 452 453 452 453 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 454 455 454 455 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 347 352 <span type="species:ncbi:10090">mouse</span>
Derived from ancient salmonid fish sequences [1], the Sleeping Beauty (SB) transposon is a member of the Tc1/mariner superfamily of cut-and-paste transposable elements [2] and has been developed as a vertebrate transformation tool [3] and germline insertional mutagen [4,5]. We and others have shown that the SB transposon is highly active in the mouse germline and can generate heritable loss-of-function mutations that lead to detectable phenotypes [4-7].
###end p 9
###begin p 10
###xml 278 288 278 288 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila</italic>
###xml 758 759 758 759 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 760 762 760 762 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 812 823 812 823 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila </italic>
###xml 852 853 852 853 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 882 884 882 884 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 49 54 <span type="species:ncbi:10090">mouse</span>
###xml 107 112 <span type="species:ncbi:10090">mouse</span>
###xml 278 288 <span type="species:ncbi:7227">Drosophila</span>
###xml 487 492 <span type="species:ncbi:10090">mouse</span>
###xml 812 822 <span type="species:ncbi:7227">Drosophila</span>
###xml 1004 1009 <span type="species:ncbi:10090">mouse</span>
Data accumulated from spontaneous and engineered mouse mutations suggests that a significant percentage of mouse genes are essential for early development. This has necessitated the creation of various genetic tools for conditional loss- or gain-of-function genetic studies. In Drosophila, the ability to regulate genes in a tissue- or temporally-specific manner has become one method to study the function of these genes. Likewise, the ability to control the expression of an essential mouse gene is one way to discover its function in tissues that are formed after lethal phenotypes are manifest. Temporal and spatial control of gene expression in mutant backgrounds can be used to determine when a gene product is required during a developmental process [8-10]. With this in mind, and taking lessons from the Drosophila literature on GAL4/UAS-based P-element transposon systems [11], we designed a SB transposon-based gene trap system that allows us to annotate the expression pattern and function of mouse genes.
###end p 10
###begin p 11
###xml 163 164 163 164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 165 166 165 166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 286 290 286 287 <italic xmlns:xlink="http://www.w3.org/1999/xlink">&#946;</italic>
###xml 791 793 788 790 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 104 108 <span type="species:ncbi:10090">mice</span>
Previous studies using the SB transposon system for generating insertional mutations in the germline of mice used various gene- and polyA-trap transposon vectors [4,5]. These vectors were designed to truncate an endogenous mRNA, incorporate coding sequences for a visible reporter like beta-Galactosidase or green fluorescent protein (GFP), and report the expression patterns of trapped genes. If a transcriptional transactivator, similar to GAL4, were used in place of a visible reporter molecule, a small amount of the molecule could lead to high levels of a secondary reporter transgene under control of a responsive promoter. Analogous to the GAL4/UAS system, the tetracycline-controlled transactivator (tTA) and Tet-response element promoter (TRE) were developed for mammalian systems [12].
###end p 11
###begin p 12
###xml 417 424 417 424 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 503 519 503 519 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sleeping Beauty </italic>
###xml 104 109 <span type="species:ncbi:10090">mouse</span>
###xml 540 545 <span type="species:ncbi:10090">mouse</span>
Here we report the creation of a mutagenic SB-based, gene-trap transposon vector that can insert into a mouse gene and express the Tet-off transcriptional transactivator (tTA) in its tissue- and temporally-regulated manner. The "gene-trap tTA" can mutate genes and record their expression patterns for functional annotation as well as create a mechanism for driving the expression of transgenes in a regulable manner in vivo. We also report several general parameters that impact the application of the Sleeping Beauty transposon system to mouse functional genomics including analysis of transposon mobilization rates in several different transgenic lines and the rescue of a mutant phenotype by remobilization.
###end p 12
###begin title 13
Results
###end title 13
###begin title 14
Creation of the gene-trap tTA system
###end title 14
###begin p 15
###xml 99 101 99 101 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 256 258 256 258 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1A</xref>
###xml 443 447 440 442 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#174; </sup>
###xml 739 748 734 743 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 749 751 744 746 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 883 885 878 880 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1A</xref>
###xml 80 89 <span type="species:ncbi:7955">zebrafish</span>
###xml 170 179 <span type="species:ncbi:7955">zebrafish</span>
###xml 323 327 <span type="species:ncbi:7962">carp</span>
###xml 360 386 <span type="species:ncbi:12104">encephalomyocarditis virus</span>
###xml 388 392 <span type="species:ncbi:12104?1.0">EMCV</span>
###xml 504 508 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
###xml 951 956 <span type="species:ncbi:10090">mouse</span>
###xml 1146 1151 <span type="species:ncbi:10090">mouse</span>
A SB transposon-based gene-trap tTA vector was first designed for and tested in zebrafish embryos [13]. The gene-trap tTA vector was shown function in somatic tissues of zebrafish and activate a TRE-regulated GFP transgene. T2/GT2/tTA and T2/GT3/tTA (Fig. 1A) are similar to the earlier gene-trap tTA (GT/tTA) and encode a carp beta-actin splice acceptor, the encephalomyocarditis virus (EMCV) internal ribosomal entry site (IRES), the Tet-Off(R) (tTA) coding sequence (Clontech, Palo Alto, CA), and the SV40 late polyadenylation signal. Modifications are described in the Materials and Methods and include an upgrade to the 'T2' versions of the SB inverted terminal repeat sequences (ITR), demonstrated to increase transposition activity in vitro [14], and the addition of stop codon sequences in each reading frame just upstream of the IRES. The T2/GT3/tTA transposon vector (Fig. 1A) was additionally modified to include a splice acceptor from the mouse hypoxanthine phosphoribosyltransferase gene (HPRT) and a V5-epitope tag on the opposite strand of the transposon. This allows the gene trap to disrupt gene expression upon insertion into a mouse gene in either orientation. If open reading frame one were conserved after splicing from the endogenous exon, the V5-epitope would be added to the truncated peptide.
###end p 15
###begin p 16
###xml 5 7 5 7 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1B</xref>
###xml 66 71 <span type="species:ncbi:10090">mouse</span>
Fig. 1B shows the method by which the gene-trap tTA can disrupt a mouse gene. When the gene-trap transposon lands in the intron of a gene, it will intercept splicing from an upstream exon and incorporate the IRES and tTA elements to form a bicistronic messenger RNA. Translation of the endogenous gene peptide is truncated at one of the stop codons incorporated just upstream of the IRES. The IRES element allows cap-independent translation initiation from the second open reading frame to produce tTA from the same mRNA. For the T2/GT2/tTA vector, an insertion into a gene in the opposite orientation is not predicted to mutate the gene, however, the T2/GT3/tTA would interrupt splicing with the HPRT splice acceptor, but will not express tTA.
###end p 16
###begin p 17
###xml 135 143 135 143 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 263 265 263 265 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1C</xref>
###xml 464 465 464 465 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 789 791 789 791 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1D</xref>
###xml 1048 1050 1048 1050 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1D</xref>
###xml 14 29 <span type="species:ncbi:10090">transgenic mice</span>
Before making transgenic mice, we validated the functionality of the gene-trap tTA as a faithful activator of reporter gene expression in vitro. First, a G418-resistance cassette was cloned into the T2/GT2/tTA transposon vector to generate T2/GT2/tTA/SVNeo (Fig. 1C). We then generated a HeLa cell line harboring a TRE-regulated luciferase transgene. Upon co-transfection of the pT2/GT2/tTA/SVNeo transposon vector plasmid and a source of SB transposase, pCMV-SB [1], the gene-trap tTA transposes at random into the HeLa cell genome. The SVNeo cassette confers G418 resistance to cells that integrate and express the transposon vector, but the gene-trap tTA cassette can intercept splicing and express tTA only if the transposon lands in an expressed gene in the correct orientation. Fig. 1D shows the luciferase activation in sixty-two individual G418-resistant clone extracts. As a control, a transposon that contained the same G418 resistance cassette, but not the splice acceptor-IRES-tTA cassette, did not activate luciferase expression (Fig. 1D, white bars). As expected, only a subset of T2/GT2/tTA/SVNeo-transgenic clones, 17 out of 50, showed activation of TRE-luciferase above background levels.
###end p 17
###begin p 18
###xml 99 101 99 101 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 218 220 218 220 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1D</xref>
###xml 227 229 227 229 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1E</xref>
###xml 717 734 717 734 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">Additional file 1</xref>
###xml 1292 1299 1292 1299 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 1207 1212 <span type="species:ncbi:10090">mouse</span>
The activity of tTA is regulable by administering the drug tetracycline or its analog doxycycline [15]. We tested this sensitivity by administering doxycycline to three of the TRE-luciferase activated clones from Fig. 1D. Fig. 1E shows the doxycycline-dependent repression of TRE-luciferase activation in each clone. Luciferase activity was reduced approximately two orders of magnitude in clones, 43 and 44, and about one order of magnitude in clone 39. Finally, to assure that gene trap tTA activation was dependent on splicing from an upstream exon of an expressed gene, 5' rapid amplification of cDNA ends (RACE) was performed with primers specific to the gene trap on mRNA extracts prepared from several clones. Additional file 1 shows the sequence tags, chromosomes and gene identification obtained for seven clones. In each case, an upstream exon of the gene is spliced into the gene-trap tTA at the predicted position (underlined). These data demonstrate that the tTA molecule can be expressed from the gene-trap tTA vector in the context of a trapped gene to activate a TRE-regulated transgene and that this activation is repressible by the addition of doxycycline. With the prospect of generating mouse strains with regulated gene-trap tTA activation, we set out to test the system in vivo.
###end p 18
###begin title 19
Parameters affecting germline mobilization rates
###end title 19
###begin p 20
###xml 782 783 782 783 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 1053 1055 1053 1055 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 1295 1296 1295 1296 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 1297 1299 1297 1299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 1555 1556 1555 1556 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 0 15 <span type="species:ncbi:10090">Transgenic mice</span>
###xml 262 267 <span type="species:ncbi:10090">mouse</span>
###xml 323 328 <span type="species:ncbi:10090">mouse</span>
###xml 1097 1101 <span type="species:ncbi:10090">mice</span>
###xml 1255 1259 <span type="species:ncbi:10090">mice</span>
###xml 1406 1410 <span type="species:ncbi:10090">mice</span>
Transgenic mice were generated with the T2/GT2/tTA and T2/GT3/tTA transposon vectors by standard pronuclear injection (see Materials and Methods). A typical result of this protocol is the head-to-tail concatenation of transgene units before integrating into the mouse genome to create a multi-copy array of transgenes in a mouse chromosome. Each transposon transgene concatemer, thus, serves as a donor site containing multiple substrates for mobilization by the SB transposase. To determine the number of gene-trap tTA transposons in each transgenic line, we performed Southern blot analysis using a restriction digest scheme that resolves the concatemerized transposons to a single band and estimated the number of copies based on its intensity (see Materials and Methods). Table 1 shows ten independent transgenic founder lines with transposon copy numbers ranging from approximately three to sixty copies. To test for mobilization of the transposons in the germline, each transgenic line was crossed to the CAGGS-SB10 transposase-expressing strain [16]. The resulting doubly transgenic "seed" mice were outcrossed to wild type animals to observe gene trap mobilization in the germline. Southern blot analysis on tail biopsy DNA from offspring of seed mice was used, as previously described [4,16], to observe the number of new transposon insertions per gamete. We averaged the insertion data from seed mice from each line to calculate the likelihood (rate per copy number) that a transposon could be mobilized from their respective concatemers (Table 1). The data demonstrates that lines with fewer copies of the transposon substrate show the lowest mobilization rates. This, however, is not a strict correlation. This is evident in comparing lines 6632 and 6657, where the former has fewer copies, but shows a higher per-copy-transposon mobilization rate of the latter.
###end p 20
###begin p 21
###xml 333 334 333 334 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 675 677 675 677 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 863 865 863 865 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2A</xref>
###xml 1056 1058 1056 1058 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2B</xref>
###xml 1205 1214 1205 1214 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Slc25a22 </italic>
###xml 1220 1221 1220 1221 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 1485 1486 1485 1486 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 1566 1568 1566 1568 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1A</xref>
###xml 1822 1824 1822 1824 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 1825 1827 1825 1827 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 41 56 <span type="species:ncbi:10090">transgenic mice</span>
###xml 753 768 <span type="species:ncbi:10090">transgenic mice</span>
###xml 1199 1204 <span type="species:ncbi:10090">mouse</span>
###xml 1355 1359 <span type="species:ncbi:10090">mice</span>
###xml 1386 1390 <span type="species:ncbi:10090">mice</span>
###xml 1875 1880 <span type="species:ncbi:10090">mouse</span>
The inability to mobilize transposons in transgenic mice with few transposons in the concatemer is consistent with our efforts to re-mobilize a single copy insertion in the genome. We analyzed the mobilization of two independently generated single copy insertions. Insertion 01-0032 was generated and described in an earlier report [4] and 02A-0016 is a gene-trap tTA insertion identified in an offspring of a T2/GT2/tTA seed male (line 4583) as described below. When SB transposons are excised from a chromosome locus during gametogenesis, host DNA repair machinery typically creates a "footprint" of a few or several base pairs while repairing the double-strand-break gap [17]. We mobilized the insertions 01-0032 and 02A-0016 by intercrossing doubly transgenic mice that harbor a single-copy transposon insertion and the CAGGS-SB10 transposase transgene (Fig. 2A). We detected transposition in about one out of every 100 offspring for either insertion by PCR amplifying the sequences that flank the donor site and sequencing to detect a footprint (Fig. 2B). Notably, remobilization of insertion 01-0032, which causes an early recessive embryonic lethal phenotype as a result of disruption of the mouse Slc25a22 gene [4], restores activity of the gene and rescues the recessive lethality associated with this insertion as heterozygous 01-0032/footprint mice are phenotypically normal mice. The inability to efficiently remobilize a single copy insertion has been reported elsewhere [6]. For this reason, we incorporated loxP sites into the T2/GT3/tTA vector (Fig. 1A), flanking the mutagenic portion of the gene-trap vector. Cre-mediated recombination in tissues and in the germline have been demonstrated and are significantly higher than the 1% mobilization rate we can achieve by remobilizing single copy insertions [18-20]. Thus, a T2/GT3/tTA gene trap disruption of a mouse gene might be rescued by expression of Cre recombinase in a tissue- or germline-specific manner.
###end p 21
###begin p 22
###xml 6 7 6 7 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 242 246 <span type="species:ncbi:10090">mice</span>
###xml 418 422 <span type="species:ncbi:10090">mice</span>
Table 1 also demonstrates that germline mobilization rates are lower in the female germline when compared to their male siblings (dashed boxes). Finally, the solid box shows the difference in transposition rates between two sibling male seed mice, one hemizygous and one homozygous for the transposase transgene. While the SB10+/+ seed male did not show increased transposition over other independently generated seed mice for the 4563 line, there was an increase over its sibling SB10+/- seed male, suggesting that we may be able to increase transposition rates by increasing the transposase dosage in future studies. The analysis of several transposon-transgenic lines has thus revealed parameters that affect transposition rates, and suggest careful line selection will be required for mutagenic programs.
###end p 22
###begin title 23
###xml 0 15 0 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sleeping Beauty</italic>
###xml 40 47 40 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
Sleeping Beauty-mediated gene insertion in vivo
###end title 23
###begin p 24
###xml 213 214 213 214 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 215 216 215 216 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 217 219 217 219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 619 636 619 636 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S2">Additional file 2</xref>
###xml 641 658 641 658 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S3">additional file 3</xref>
###xml 937 938 937 938 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 939 940 939 940 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 961 962 961 962 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 1240 1242 1240 1242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3A</xref>
###xml 121 125 <span type="species:ncbi:10090">mice</span>
###xml 300 304 <span type="species:ncbi:10090">mice</span>
###xml 367 372 <span type="species:ncbi:10090">mouse</span>
###xml 497 502 <span type="species:ncbi:10090">mouse</span>
###xml 1155 1160 <span type="species:ncbi:10090">mouse</span>
###xml 1221 1226 <span type="species:ncbi:10090">mouse</span>
T2/GT2/tTA line 4563 and T2/GT3/tTA line 6660 were useful to identify new transposon insertions in the offspring of seed mice. Techniques for cloning transposon-genomic DNA junction sequences have been described [1,4,21]. The chromosomal positions of thirty transposition events in offspring of seed mice from line 4563 were identified by querying the ENSEMBL online mouse genome database using the BLAST function. The T2/GT3/tTA line 6660 was used in a study of mutations induced specifically on mouse chromosome 11 and the insertion data from this line will be reported elsewhere (A.M.G., manuscript in preparation). Additional file 2 and additional file 3 show the data accumulated from the thirty T2/GT2/tTA events. Consistent with previous reports, the T2/GT2/tTA transposons exhibit local hopping, where a significant percentage of new insertions cluster in a particular region of the genome, and the insertions can land in genes [4,5]. Three-primer PCR [3] can readily be used to genotype carriers for any specific transposon insertion. Because we were interested in testing the function of the gene-trap tTA vector in the context of an endogenous mouse gene, carriers of insertions 02A-0001 and 02A-0002, both in mouse genes, (Fig. 3A) were propagated for further study.
###end p 24
###begin title 25
Molecular characterization of gene-trap tTA function
###end title 25
###begin p 26
###xml 84 89 84 89 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Car12</italic>
###xml 161 180 161 180 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ENSMUSG00000066992 </italic>
###xml 186 188 186 188 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3A</xref>
###xml 213 215 213 215 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3B</xref>
###xml 254 260 254 260 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Car12 </italic>
###xml 476 482 476 482 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Car12 </italic>
###xml 542 548 542 548 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Car12 </italic>
###xml 552 557 552 557 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Car12</italic>
###xml 783 789 783 789 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Car12 </italic>
###xml 1098 1104 1098 1104 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Car12 </italic>
###xml 248 253 <span type="species:ncbi:10090">mouse</span>
Insertion number 02A-0001 is in the first intron of the carbonic anhydrase-12 gene (Car12), while 02A-0002 is inserted into intron 8 of the predicted novel gene ENSMUSG00000066992 (Fig. 3A). The top panel in Fig. 3B shows the expression pattern of mouse Car12 by reverse-transcriptase PCR (RT-PCR) on RNA extracts from several wild type tissues using primers in exons 1 and 5. If the gene trap is splicing properly, the IRES and tTA sequences should be fused to exon 1 of the Car12 mRNA. The second panel shows RT-PCR detection of endogenous Car12 and Car12-IRES-tTA bicistronic transcripts in RNA samples taken from a heterozygous carrier of insertion 02A-0001. Nested PCR was necessary to detect the fusion transcript in some tissues. Comparing the wild type expression pattern of Car12 mRNA and the fusion transcript, it is apparent that expression of the trapped mRNA is tissue specific as predicted. The fusion transcript can be detected in the heart of the carrier, but not wildtype heart RNA extracts. We attribute this to the extra sensitivity of the nested PCR and suspect that endogenous Car12 is expressed in the heart at a low level.
###end p 26
###begin p 27
###xml 346 348 343 345 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3C</xref>
###xml 7 11 <span type="species:ncbi:7962">carp</span>
###xml 528 533 <span type="species:ncbi:10090">mouse</span>
###xml 648 652 <span type="species:ncbi:7962">carp</span>
If the carp beta-actin splice acceptor is efficient, it should truncate the endogenous gene mRNA after the nearest upstream exon. Total RNA extracts from wild type, and heterozygous or homozygous carriers of both insertions 02A-0001 and 02A-0002 were probed for expression of endogenous Car12 or ENSMUSG00000066992 transcripts respectively. Fig. 3C shows complete ablation of Car12 mRNA in the kidney and brain of a homozygous carrier of insertion 02A-0001. Expression of ENSMUSG00000066992, detectable by RT-PCR exclusively in mouse brain (data not shown), was not ablated in homozygous carriers of insertion 02-0002, however, suggesting that the carp beta-actin splice acceptor does not work efficiently in each case.
###end p 27
###begin p 28
###xml 15 21 15 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Car12 </italic>
###xml 312 314 312 314 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 379 381 379 381 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 389 391 389 391 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3C</xref>
###xml 636 638 636 638 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 690 692 690 692 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3C</xref>
###xml 28 32 <span type="species:ncbi:10090">mice</span>
###xml 279 284 <span type="species:ncbi:10090">mouse</span>
Interestingly, Car12 mutant mice demonstrate reduced fitness, as an intercross of 02A-0001 carriers results in non-mendelian inheritance of the homozygous class (data not shown). The expression of the carbonic anhydrase (CA-XII) has been previously localized to the membranes of mouse kidney, colon, and testes [22]. The CA-XII peptide has been previously reported to be 46 kDA [23]. Fig. 3C shows the reduction of CA-XII expression in the heterozygous kidney and absence in the homozygous kidney. Antibody cross-reaction with a ~ 30-kDa peptide is consistent with cross-reactions previously seen in kidney extracts with this antibody [23], and serves as a loading control (arrowhead, Fig. 3C).
###end p 28
###begin title 29
###xml 65 72 65 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
Tissue-specific activation of a TRE promoter-regulated transgene in vivo
###end title 29
###begin p 30
###xml 10 18 10 18 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 410 412 410 412 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 700 705 700 705 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Car12</italic>
###xml 775 777 775 777 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3B</xref>
###xml 1312 1314 1312 1314 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3A</xref>
###xml 1319 1321 1319 1321 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4A</xref>
###xml 1658 1660 1658 1660 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4B</xref>
###xml 1925 1944 1925 1944 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ENSMUSG00000066992 </italic>
###xml 1950 1952 1950 1952 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3C</xref>
###xml 206 210 <span type="species:ncbi:10090">mice</span>
###xml 298 302 <span type="species:ncbi:10090">mice</span>
###xml 1543 1547 <span type="species:ncbi:10090">mice</span>
###xml 1747 1762 <span type="species:ncbi:10090">transgenic mice</span>
###xml 1836 1840 <span type="species:ncbi:10090">mice</span>
The final in vivo test for the gene-trap tTA system is to determine whether the vectors can activate a TRE promoter-regulated transgene in a tissue-specific manner. We obtained the Tg(tetL)1Bjd/J strain of mice, transgenic for a TRE-regulated luciferase transgene, from Jackson Laboratories. These mice have been previously shown to respond to tissue-specific tTA expression in a doxycycline-dependent manner [24]. Luciferase activity assays from individual organ extracts from a 02A-0001; Tg(tetL)1Bjd/J doubly transgenic animals showed activation of luciferase in all tissues tested when compared to singly transgenic controls (data not shown). This result was surprising because the trapped gene, Car12, is not expressed in the liver (among other tissues) by RT-PCR (Fig. 3B). Insertion 02A-0001 is the result of local transposition, and thus is linked to the original concatemer of transposons. We reasoned that these linked T2/GT2/tTA transgenes present in carriers of this insertion might express tTA, therefore resulting ubiquitous luciferase expression when crossed to the Tg(tetL)1Bjd/J strain. To circumvent this issue, we focused on insertions that were not the result of local hopping and would segregate from other transposable elements. Insertions 02A-0002, 03A-0184, 03A-0217, and 03A-0241 (Figs. 3A and 4A) are the result of non-local transposition of T2/GT2/tTA or T2/GT3/tTA transposons in their respective transposon transgenic strains. Carriers of each of these gene insertions were crossed to the Tg(tetL)1Bjd/J strain of mice with the hope of visualizing tissue-specific, tTA-dependent transactivation of luciferase. As predicted, Fig. 4B shows weak activation of luciferase in the brain of a 02A-0002; Tg(tetL)1Bjd/J doubly transgenic mice, but not other tissues. This pattern was reproduced in three out of four mice. As shown above, this insertion does not completely disrupt the brain expression of ENSMUSG00000066992 (Fig. 3C), but some splicing into the T2/GT2/tTA splice acceptor must occur to allow tissue-specific expression of the tTA.
###end p 30
###begin p 31
###xml 229 231 229 231 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 547 549 538 540 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5A</xref>
###xml 915 917 906 908 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4A</xref>
###xml 1113 1119 1104 1110 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ms4a6c</italic>
###xml 1160 1165 1151 1156 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Itgb3</italic>
###xml 1243 1245 1234 1236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 380 395 <span type="species:ncbi:10090">transgenic mice</span>
###xml 677 692 <span type="species:ncbi:10090">transgenic mice</span>
###xml 1204 1209 <span type="species:ncbi:10090">mouse</span>
Hasan, et al. (2001) demonstrated that non-invasive imaging of luciferase expression of a similar tTA-activated strain using an intensified charge-coupled device camera system after subcutaneous injection of luciferin substrate [25]. We used the Xenogen IVIStrade mark100 Imaging System to see if tissue-specific patterns could be detected in gene-trap tTA; Tg(tetL)1Bjd/J doubly transgenic mice. Light emissions are often observed in the extremities, nose, ears, and tails of control Tg(tetL)1Bjd/J in a tTA-independent manner in our hands (Fig. 5A). No additional tissue-specific signals were initially detected in 02A-0001; Tg(tetL)1Bjd/J or 02A-0002; Tg(tetL)1Bjd/J doubly transgenic mice, suggesting that expression of luciferase levels detected in the organ extracts were not sufficient to be detected by the imager. Likewise, when crossed to the Tg(tetL)1Bjd/J strain, insertions 03A-0184 and 03A-0217 (Fig. 4A) showed no activation of luciferase by imaging or by luminometer readings of organ extracts (data not shown). While the expression pattern of Membrane-spanning 4-domains, subfamily A, member 6C (Ms4a6c) is not characterized, Integrin beta 3 (Itgb3) has been localized to the developing mouse heart in early embryonic stages [26]. It is possible that we missed the expression of these gene-trap tTA insertions because these genes are not expressed in adult tissues.
###end p 31
###begin p 32
###xml 230 232 230 232 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5A</xref>
###xml 464 470 464 470 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MacF1 </italic>
###xml 610 612 610 612 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 683 689 683 689 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MacF1 </italic>
###xml 707 709 707 709 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5B</xref>
###xml 823 829 823 829 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MacF1 </italic>
###xml 943 949 943 949 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MacF1 </italic>
###xml 1086 1091 1086 1091 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MacF1</italic>
###xml 113 128 <span type="species:ncbi:10090">transgenic mice</span>
###xml 130 135 <span type="species:ncbi:10090">mouse</span>
###xml 186 191 <span type="species:ncbi:10090">mouse</span>
###xml 565 570 <span type="species:ncbi:10090">mouse</span>
###xml 889 894 <span type="species:ncbi:10090">mouse</span>
###xml 1151 1155 <span type="species:ncbi:10090">mice</span>
In contrast, a striking pattern of luciferase expression was captured by imaging 03A-0241; Tg(tetL)1Bjd/J doubly transgenic mice (mouse 936) when compared to singly 03A-0241 transgenic (mouse 933) or Tg(tetL)1Bjd/J controls (Fig. 5A). Light emission patterns were detected from anatomical origins corresponding to the sternum, spleen, femurs and vertebrae, presumably reflecting luciferase activation in a component of the bone marrow and hematopoietic cells. The MacF1 gene has more than 100 exons and has been reported to be expressed in multiple isoforms in the mouse with high levels produced in the lung [27]. Using primers in exons that flank the 03A-0241 insertion to amplify MacF1 transcripts, Fig. 5B demonstrates that at least two splice variants of different sizes are variably expressed in several tissues, but MacF1 is not normally expressed in the bone marrow of a wild-type mouse. This suggests that the 03A-0241 insertion into MacF1 may cause abnormal expression of the gene in the bone marrow and hematopoietic cells. However, multiple attempts to amplify the chimeric MacF1-IRES-tTA transcript from bone marrow extracts from carrier mice by RT-PCR were unsuccessful in identifying this spliced transcript.
###end p 32
###begin p 33
###xml 86 92 86 92 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MacF1 </italic>
###xml 222 224 222 224 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5C</xref>
###xml 354 356 354 356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5A</xref>
###xml 457 458 457 458 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 519 525 519 525 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MacF1 </italic>
###xml 717 723 717 723 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MacF1 </italic>
###xml 904 906 904 906 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5C</xref>
###xml 80 85 <span type="species:ncbi:10090">mouse</span>
###xml 150 155 <span type="species:ncbi:10090">mouse</span>
###xml 202 206 <span type="species:ncbi:10090">mice</span>
###xml 241 245 <span type="species:ncbi:10090">mice</span>
###xml 404 408 <span type="species:ncbi:10090">mice</span>
###xml 498 503 <span type="species:ncbi:10090">mouse</span>
###xml 539 544 <span type="species:ncbi:10090">mouse</span>
###xml 1226 1230 <span type="species:ncbi:10090">mice</span>
###xml 1250 1254 <span type="species:ncbi:10090">mice</span>
To determine whether this pattern was linked only to insertion 03A-0241 and the mouse MacF1 gene, Southern blots and genotyping PCR were performed on mouse 936 (and siblings 931-935) and his offspring (mice 949-976) (Fig. 5C). Surprisingly, mice that inherited insertion 03A-0241 by PCR showed linkage to the concatemer donor site by Southern blot (Fig. 5A, arrowhead). This was unexpected because these mice were generated from T2/GT3/tTA line 6660 (Table 1), which has a transposon donor site on mouse chromosome 11. MacF1 is located on mouse chromosome 4 at 57.4 cM, thus the Southern data suggests that a large portion of the chromosome-11 concatemer had translocated by some mechanism to chromosome-4. Thus, the MacF1 insertion on chromosome 4 is still genetically linked to a translocated donor concatemer of multiple T2/GT3/tTA transposons in addition to other linked single-copy insertions (Fig. 5C, arrows). Repeated attempts to identify these other linked chromosome-4 insertions by our cloning techniques and 5'RACE for trapped sequences in bone marrow extracts were unsuccessful in identifying the origin of this tissue-specific gene-trap tTA expression. Nevertheless, the pattern seen in 03A-0241; Tg(tetL)1Bjd/J mice is unique to these mice, as it is not seen in carriers of other T2/GT2/tTA or T2/GT3/tTA insertions (with or without associated concatemers) when crossed to the Tg(tetL)1Bjd/J strain (above and data not shown).
###end p 33
###begin p 34
###xml 169 171 169 171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5D</xref>
###xml 266 267 266 267 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 500 508 500 508 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 611 613 611 613 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 614 616 614 616 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 617 619 617 619 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 794 796 794 796 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5E</xref>
###xml 869 871 869 871 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5D</xref>
###xml 138 142 <span type="species:ncbi:10090">mice</span>
###xml 453 458 <span type="species:ncbi:10090">mouse</span>
###xml 783 787 <span type="species:ncbi:10090">mice</span>
The tissue-specific luciferase pattern in carriers of this insertion could be reproducibly transmitted through the germline to offspring (mice 962-964 and 971-973, Fig. 5D). The upper range of luciferase activation from each offsrpring, measured in photons/second/cm2, ranged approximately a thousand-fold (scale bars). We attribute these differences to differences in the levels of cap-independent translation of the tTA molecule from the IRES in each mouse. Finally, other groups have demonstrated in vivo sensitivity of tTA-dependent activation of gene expression to tetracycline, or its analog doxycycline [24,28,29]. We determined whether we could control gene-trap tTA activation of luciferase by administering doxycycline to the drinking water of the 03A-0241; Tg(tetL)1Bjd/J mice. Fig. 5E demonstrates absence of luciferase signal in the same animals from Fig. 5D, after six days of treatment, suggesting complete repression of the tTA-dependent luciferase activation.
###end p 34
###begin title 35
Discussion
###end title 35
###begin p 36
###xml 156 165 156 165 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 169 176 169 176 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 740 747 740 747 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 508 513 <span type="species:ncbi:10090">mouse</span>
###xml 595 600 <span type="species:ncbi:10090">mouse</span>
###xml 899 903 <span type="species:ncbi:10090">mice</span>
We examined the utility of a SB transposon-base gene trap vector that expresses the Tet-off transcriptional transactivator in the patterns of trapped genes in vitro and in vivo. The gene-trap tTA demonstrated full utility in cultured cells, having the ability to insert in genes, trap the splicing of those genes to express the tTA transcription factor which, in turn, could activate a TRE-regulated transgene in a doxycycline-dependent manner. Likewise, analysis of gene-trap tTA transposon insertions into mouse genes revealed that the vector system can completely disrupt the expression of a mouse gene in some cases and can tissue-specifically activate expression of a TRE promoter-regulated transgene in a doxycycline-dependent manner in vivo. While ultimately this vector system can function as designed, several observations suggest we need a more optimal approach for creating a resource of mice that express tTA in developmentally-controlled patterns.
###end p 36
###begin p 37
###xml 469 470 469 470 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 713 716 713 716 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SB </italic>
###xml 813 815 813 815 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 49 54 <span type="species:ncbi:10090">mouse</span>
Germline SB transposon mobilization rates in the mouse germline are variable and ranged from less than one in twenty to nearly three events per gamete. An evaluation of several different transposon-transgenic lines has given us insight into the potential the SB system to perform regional mutagenesis throughout the genome. The genomic location of the transposon donor site, along with copy number, impacts the germline mobilization rate from any concatemer (see Table 1). This suggests that not all parts of the genome are equally accessible to SB transposition. Understanding the mechanisms behind this "mobilization position effect" will likely require an increased understanding about molecular regulators of SB transposition, but may include a well known director of position effect, heterochromatinization [30].
###end p 37
###begin p 38
###xml 46 49 46 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SB </italic>
###xml 97 105 97 105 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 291 297 291 297 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Car12 </italic>
###xml 413 431 413 431 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ENSMUSG00000066992</italic>
###xml 842 844 842 844 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 845 847 845 847 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 998 1000 998 1000 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 134 139 <span type="species:ncbi:10090">mouse</span>
###xml 211 216 <span type="species:ncbi:10090">mouse</span>
###xml 285 290 <span type="species:ncbi:10090">mouse</span>
###xml 518 523 <span type="species:ncbi:10090">mouse</span>
###xml 924 929 <span type="species:ncbi:10090">mouse</span>
As demonstrated in previous studies and here, SB transposon-based gene trap vectors can function in vivo to disrupt the expression of mouse genes. The T2/GT2/tTA vector can completely ablate the expression of a mouse gene as demonstrated by the null mutation that was generated in the mouse Car12 gene. Not all gene insertions completely disrupt gene expression however, as in the case of insertion 02A-0002 into ENSMUSG00000066992. While hypomorphic mutations may be valuable to discover the function of an essential mouse gene, this has lead to ideas on how to improve the efficacy of future vectors. Splice acceptors derived from different genes, termination sequences (polyadenylation signals) and other functional sequences have been used in several ES cell plasmid- and retroviral-based gene-trapping studies with varying efficiencies [31-33]. Drawing data from other groups will lead to improved vectors for trapping mouse genes and perhaps lead to vectors to trap certain classes of genes [34].
###end p 38
###begin p 39
###xml 105 107 105 107 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5D</xref>
###xml 387 391 387 391 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gtx </italic>
###xml 409 411 409 411 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 380 386 <span type="species:ncbi:10090">murine</span>
The activation of luciferase by the tetracycline-controlled transactivator varied rougly 1000-fold (Fig. 5D) when expressed from the IRES in the gene-trap tTA. Once again, improvements to the functional components of the gene trap vector may lead to more reliable and greater expression of the transactivator. Alternative IRES elements like the 9-nucleotide IRES element from the murine Gtx homeodomain gene [35], or eliminating the IRES entirely, may allow for more consistent tTA expression.
###end p 39
###begin p 40
###xml 25 33 25 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 68 69 68 69 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 127 133 127 133 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MacF1 </italic>
###xml 886 891 886 891 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MacF1</italic>
###xml 1033 1037 <span type="species:ncbi:10090">mice</span>
###xml 1220 1224 <span type="species:ncbi:10090">mice</span>
###xml 1497 1501 <span type="species:ncbi:10090">mice</span>
The brilliant pattern of in vivo luciferase expression seen if Fig. 5 was initially thought to originate from insertion in the MacF1 gene. Published reports suggested that neither the bone marrow, nor hematopoietic cells are in the normal expression domain of this gene. Upon further molecular characterization, we discovered that this gene was not spliced into the gene-trap tTA, and by Southern blot, found it was tightly linked to other insertions as well as the concatemer. It seems more likely that the pattern of tTA-dependent luciferase activation seen in carriers of the 03A-0241 insertion comes from one of these linked transposons. Efforts to find the source of this expression by 5'RACE were unfortunately unsuccessful. We propose that in the case of insertion 03A-0241, the concatemer translocated to chromosome 4 first, then a single copy of T2/GT3/tTA hopped locally into MacF1. We have observed similar and other types of genomic rearrangements associated with transposition from the chromosome-11 donor site in other mice (A.M.G., manuscript in preparation). These observations would suggest that gene-trap tTA mobilization in the germline may not be the most efficient means of generating a resource of mice with tissue-specific tTA expression patterns. It is not clear, however, that these large donor site insertions are not rare events that could be tolerated. Independent insertions, unlinked to the concatemer or other transposons, are frequently recovered. By pre-selecting mice that do not inherit the concatemer by Southern blot or PCR analysis, a screen would largely avoid the complications of linked transposons.
###end p 40
###begin p 41
###xml 137 145 137 145 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 425 426 425 426 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 599 600 599 600 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 199 204 <span type="species:ncbi:10090">mouse</span>
###xml 320 325 <span type="species:ncbi:10090">mouse</span>
###xml 450 465 <span type="species:ncbi:10090">transgenic mice</span>
An alternative and relatively facile approach would be to inject a linearized plasmid harboring the gene-trap tTA transposon, along with in vitro-transcribed transposase messenger RNA, into one-cell mouse embryos. In the one-cell embryo, the transposase mRNA is translated and transposase catalyzes integration into the mouse genome at rates that are two to three-fold higher than standard pronuclear injection of naked DNA [3]. This method produces transgenic mice with insertions distributed randomly across the genome, and multiple linkage groups are frequently obtained from a single injection [3]. This would be another method to avoid the complications of linked insertions and concatemers.
###end p 41
###begin p 42
###xml 19 23 19 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAL4</italic>
###xml 181 183 181 183 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 233 235 233 235 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 429 437 429 437 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 646 655 646 655 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in utero </italic>
###xml 656 658 656 658 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 659 661 659 661 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 808 810 805 807 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 820 822 817 819 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 274 279 <span type="species:ncbi:10090">mouse</span>
###xml 679 684 <span type="species:ncbi:10090">mouse</span>
Finally, using the GAL4/UAS enhancer trap systems used in the fly, expression-based screening has been useful for identifying genes with similar or overlapping expression patterns [36] and for tissue-specific overexpression studies [37]. As we have shown here, a transgenic mouse expressing firefly luciferase under the control of the tet-response enhancer/promoter (TRE) can be coupled with the gene-trap tTA system to identify in vivo patterns with an intensified CCD camera system. In a screen, this type of imaging could be used to identify gene trap insertions that lead to tTA expression in a particular tissue or developmental stage, even in utero [38,39]. Alternatively, mouse strains for other TRE-regulated transgenes have been created, allowing for tTA-dependent expression of beta-galactosidase [40] or GFP [41]. If the efficiency of the gene-trap tTA transposon can be improved, these strains could be used by any lab to identify tissue-specific patterns.
###end p 42
###begin title 43
Conclusion
###end title 43
###begin p 44
###xml 365 367 365 367 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
###xml 368 370 368 370 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B44">44</xref>
###xml 18 23 <span type="species:ncbi:10090">mouse</span>
###xml 75 80 <span type="species:ncbi:10090">mouse</span>
###xml 180 185 <span type="species:ncbi:10090">mouse</span>
###xml 443 448 <span type="species:ncbi:10090">mouse</span>
###xml 745 750 <span type="species:ncbi:10090">mouse</span>
As a tool for the mouse community, introducing a gene-trap tTA vector into mouse genes with different spatial and temporal expression patterns would create a valuable tool for the mouse genetic toolbox. Tissue-specific promoters can control the expression of transactivators like tTA and rtTA (reverse tetracycline-controlled transactivator) in transgenic animals [42-44]. Having tissue-specific and temporal control of gene expression in any mouse tissue at any developmental stage could allow for the dissection of biological gene functions that were previously masked by a phenotype such as lethality. An SB-based transposon vector is well suited to accomplish this task by introducing precisely integrated functional reporter units into the mouse genome. In addition, an improved gene-trap tTA could provide more reliable expression of the transactivator than a transgene construct since transcription is regulated in the context of an endogenous gene and is thus less likely to be subject to the position effect variegation that can hinder the expression of transgenes.
###end p 44
###begin title 45
Methods
###end title 45
###begin title 46
Cloning gene-trap tTA transposon vectors
###end title 46
###begin p 47
###xml 63 80 63 80 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S4">Additional file 4</xref>
###xml 165 171 165 171 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al </italic>
###xml 179 181 179 181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 467 470 464 467 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Age</italic>
###xml 509 512 506 509 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sma</italic>
###xml 514 517 511 514 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Age</italic>
###xml 594 597 591 594 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Eco</italic>
###xml 600 603 597 600 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pst</italic>
###xml 656 660 653 657 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hind</italic>
###xml 689 691 686 688 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 775 779 772 776 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hind</italic>
###xml 806 808 803 805 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 819 822 816 819 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Eco</italic>
###xml 213 217 <span type="species:ncbi:7962">carp</span>
All primer/oligo sequences for PCR and cloning are provided in Additional file 4. All gene-trap tTA vectors are descendent of pGT/tTA, originally described in Clark et al . 2004 [13]. An artificial exon (based on carp beta-actin exon 2), with stop codons in each reading frame, was created by annealing four oligos (AMG049-AMG052), filling in the gaps with Klenow DNA polymerase, ligation with T4 DNA ligase, PCR amplifying with AMG049 and AMG051, and subcloning the AgeI fragment into the partially-digested SmaI-AgeI fragment of pGT/tTA to create pGT2/tTA. Subcloning the exonuclease-treated EcoRV-PstI fragment of pGT2/tTA into the Klenow-treated blunt HindIII fragment of pT2/HindIII [14] generated pT2/GT2/tTA. pT2/GT2/SVNeo was created by subcloning the Klenow-treated HindIII fragment of pT2/SVneo [14] into the EcoRV fragment of pT2/GT2/tTA.
###end p 47
###begin p 48
###xml 114 117 114 117 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nhe</italic>
###xml 258 261 258 261 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nhe</italic>
###xml 298 306 298 306 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 562 565 562 565 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nhe</italic>
###xml 587 590 587 590 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nhe</italic>
###xml 633 636 633 636 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nhe</italic>
###xml 715 718 715 718 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nhe</italic>
###xml 720 723 720 723 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Spe</italic>
###xml 777 780 777 780 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xba</italic>
###xml 985 988 985 988 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Eag</italic>
###xml 1040 1043 1040 1043 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Eag</italic>
###xml 1136 1139 1136 1139 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Eag</italic>
###xml 1178 1181 1178 1181 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Eag</italic>
###xml 1249 1257 1249 1257 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GASTRIN </italic>
###xml 1341 1344 1341 1344 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Eag</italic>
###xml 1542 1544 1542 1544 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
###xml 1739 1742 1739 1742 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Spe</italic>
###xml 298 305 <span type="species:ncbi:110766|species:ncbi:562">E. coli</span>
###xml 1243 1248 <span type="species:ncbi:9606">human</span>
The construction of pT2/GT3/tTA was a multi-step process to add additional features to the GT2 version. First, an NheI site was added to pT2/GT2/tTA by PCR amplifying the entire plasmid with primers AG023 and AG024, containing a 12-bp overlap containing the NheI site sequence, and transformation. E. coli repairs the plasmid by homologous recombination in the overlapped region, resulting in the plasmid pT2/GT2/tTA/NheI. A loxP site was made by annealing two oligos (AG025 and AG026) containing the 34-bp loxP sequence with overhanging 4-base cohesive ends to NheI and cloned into the NheI site of pT2/GT2/tTA/NheI, destroying the NheI site on one side, and adding the loxP sequence to make pT2/GT2/tTA/loxP. The NheI-SpeI fragment of pT2/GT2/tTA/loxP was subcloned into the XbaI fragment of the transposon vector pT2/HB, which has a multiple cloning site, to create pT2/GT2/tTA/loxP-2. 70-mer oligos (SA/V5-1 and SA/V5-2) containing the HPRT splice acceptor and V5 epitope tag with EagI compatible ends were annealed and cloned into the EagI site of pT2/GT2/tTA/loxP-2 to make pT2/GT2/tTA/loxp/SA-V5. In the process, one side of the EagI site was destroyed, leaving a single EagI site. A 32-bp transcriptional termination sequence from the human GASTRIN gene was created by overlapping oligos (Termin-1 and Termin-2) and cloned into this EagI site of pT2/GT2/tTA/loxp/SA-V5 to make pT2/GT2/tTA/loxp/SA-V5/Termin. This sequence was shown to enhance transcriptional termination in plasmid vectors when downstream of polyadenylation signals [45], and was included to increase the chances of mRNA truncation, and thus mutation, in the gene trap. Finally, a second loxP site was made by annealing the same oligos above and ligation into the SpeI site of pT2/GT2/tTA/loxp/SA-V5/Termin to make the final product, pT2/GT3/tTA.
###end p 48
###begin title 49
Generation of Tre-Luciferase/Puro cell line and in vitro gene trap testing
###end title 49
###begin p 50
###xml 515 524 515 524 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
pTRE-Luc was kindly provided by Dr. Perry Hackett's lab and was co-transfected with the plasmid pKO Select-Puro (Stratagene, La Jolla, CA) into HeLa cells using Mirus TransIT-LT1 reagent (Promega, Madison, WI). After puromycin resistant clones were isolated, ten clones were tested for inducibility by pTet-off (Clontech, Palo Alto, CA). One clone TLP-10 showed a four-log increase in luciferase expression over background in the presence of transfected pTet-off (data not shown), and was subsequently used for the in vitro studies presented here.
###end p 50
###begin p 51
###xml 80 81 80 81 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 140 142 139 141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 690 693 <span type="species:ncbi:9685">cat</span>
pT2/GT2/tTA/SVNeo was transfected into the TLP-10 cell line along with pCMV-SB [1], and clones were selected in 800 mug/mL G418. pT2/SVNeo [14] was used as a control. Fifty of these clones and twelve control clones were grown to confluency on 60 mm plates and cells harvested with Promega's Cell Culture Lysis Reagent for luciferase assays. Luciferase assays were performed on 20 muL of lysis extract using 100 muL of Promega's Luciferase Assay Substrate and a Lumat LB 9507 luminometer (Berthold, Bundoora, Australia) with a 15 second measuring time. Relative light unit (RLU) measurements were normalized to total protein concentration as determined by Bradford assay. Doxycycline (Sigma cat. #D-9891) was added to a final concentration of 2 mM to repress tTA-induction of TRE-Luciferase in clones 39, 43, and 44.
###end p 51
###begin title 52
RT-PCR and 5' rapid amplification of cDNA ends (RACE)
###end title 52
###begin p 53
###xml 51 68 51 68 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S4">Additional file 4</xref>
###xml 142 146 142 144 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#174; </sup>
###xml 1066 1067 1017 1018 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 103 108 <span type="species:ncbi:10090">mouse</span>
###xml 435 440 <span type="species:ncbi:10090">mouse</span>
All primer/oligo sequences for PCR are provided in Additional file 4. Total RNA from cultured cells or mouse tissues was extracted with Trizol(R) (Invitrogen, Carlsbad, CA). RT-PCR was performed using the one-step RobusTtrade mark I RT-PCR Kit (Finnzymes, Espoo, Finland) according to the manufacturer's protocol. A template-switching reaction with Superscript III (Invitrogen) was used to make template for 5'RACE on cultured cell or mouse tissue RNA extract. 250 ng total RNA was mixed with 1 muM each of primers GT2-RT3 and RACE-1, along with 0.01 M dithiothreitol, 500 muM dNTPs, and 1 unit of Superscript III. The mixture was cycled six times at 52degreesC for 10', 50degreesC for 15', and then gradually cooled from 50degreesC to 37degreesC over two minutes before a final extension for 90" at 37degreesC. Template was diluted ten-fold in water and 2 muL was used for primary 5'RACE PCR. Briefly, the template was amplified in a 50 muL PCR reaction supplemented with primers GT2-RT3 (0.4 muM), KJC-002 (0.04 muM) and KJC-003 (0.1 muM), 200 muM dNTPS, 2 mM MgCl2, and 1 unit of Taq DNA polymerase (CLP, San Diego, CA). The PCR machine was programmed for touchdown PCR at 95degreesC for 3', 10 cycles of 95degreesC for 30", 65degreesC for 30" (-0.5degreesC per cycle), 70degreesC for 2', and then 25 cycles of 95degreesC for 30", 60degreesC for 30", and 70degreesC for 2'. The primary RACE reaction was diluted 1:50 and 2 muL used in a nested PCR under the same exact conditions, except supplemented with 0.5 muM of each primer GT2-RT2 and KJC-004.
###end p 53
###begin title 54
###xml 40 44 <span type="species:ncbi:10090">mice</span>
Generation of T2/GT2/tTA and T2/GT3/tTA mice by pronuclear injection, fluorescent in situ hybridization, and Southern blotting
###end title 54
###begin p 55
###xml 12 15 12 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fsp</italic>
###xml 17 21 17 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink">-Sap</italic>
###xml 62 65 62 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fsp</italic>
###xml 67 71 67 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink">-Sap</italic>
###xml 368 373 368 373 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HinP1</italic>
###xml 952 954 952 954 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B46">46</xref>
###xml 1037 1040 1037 1040 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bam</italic>
###xml 1122 1125 1122 1125 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nco</italic>
###xml 1127 1131 1127 1131 <italic xmlns:xlink="http://www.w3.org/1999/xlink">-Sph</italic>
###xml 1184 1187 1184 1187 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bam</italic>
###xml 1315 1317 1315 1317 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1A</xref>
###xml 1507 1510 1507 1510 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bam</italic>
###xml 1528 1530 1528 1530 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5C</xref>
###xml 248 252 <span type="species:ncbi:10090">mice</span>
###xml 752 757 <span type="species:ncbi:10090">mouse</span>
The 3379-bp FspI -SapI fragment of pT2/GT2/tTA or the 3738-bp FspI -SapI fragment of pT2/GT3/tTA were gel-purified, ethanol precipitated twice, and resuspended in 5 mM Tris-Cl (pH 7.5), 0.1 mM EDTA for pronuclear injection into the FVB/N strain of mice (Charles River Laboratories, Wilmington, MA). The pT2/GT3/tTA fragment was co-injected with the similarly-prepared HinP1I fragment of the plasmid pTYBS [Overbeek, 1991 #211], a tyrosinase minigene construct kindly provided by Dr. Paul Overbeek, in an attempt to coat-color mark animals that inherit the transposon/tyrosinase minigene transgenic insertion site. Expression of the tyrosinase, for unknown reasons, was not evident in any of the founders (data not shown). FISH on T2/GT3/tTA transgenic mouse lines was performed on splenic lymphocytes using standard techniques, and performing nick translation to label the pT2/GT3/tTA plasmid or whole BAC DNA from the Wellcome Trust Sanger Institute [46] were used as a probe. Standard Southern blotting techniques were used to analyze BamHI-digested genomic DNA from founders and subsequent generations using the 842-bp NcoI -SphI fragment of the tTA open reading frame as a probe. BamHI restricts each copy in any T2/GT2/tTA or T2/GT3/tTA concatemer to a single band at 2124-bp or 2236-bp respectively (see Fig. 1A). Transposons mobilized from the concatemer to a genomic site are detected as bands of variable size which are larger than the concatemer band, their size determined by the nearest genomic BamHI site (see Fig. 5C).
###end p 55
###begin title 56
Western blotting for CA-XII expression
###end title 56
###begin p 57
###xml 305 316 <span type="species:ncbi:3704">horseradish</span>
###xml 344 350 <span type="species:ncbi:9986">rabbit</span>
Whole kidney extracts were probed with a polyclonal CA-XII antibody kindly provided by the laboratory of Dr. William Sly. 50 mug total protein was run on a 10% SDS-PAGE (Invitrogen) and transferred to PVDF and probed with a 1:1000 dilution of anti-CAXII primary antibody followed by a 1:10000 dilution of horseradish peroxidase-conjugated Anti-rabbit IgG secondary (Amersham Biosciences) in TBST (10 mM Tris-HCl, pH 7.5, 150 mM NaCl, 0.1 % Tween 20) supplemented with 1% dry milk.
###end p 57
###begin title 58
###xml 0 8 0 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In vivo </italic>
In vivo luciferase imaging and analysis of luciferase expression, doxycycline treatment
###end title 58
###begin p 59
###xml 52 58 52 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al </italic>
###xml 68 70 68 70 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B47">47</xref>
###xml 326 335 326 335 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 0 15 <span type="species:ncbi:10090">Transgenic mice</span>
###xml 170 174 <span type="species:ncbi:10090">mice</span>
Transgenic mice were imaged as described in Wilber, et al . (2005) [47], using luciferin from Xenogen Corporation (Alameda, CA). For luciferase assays on organ extracts, mice were sacrificed, and whole organs dissected and homogenized in Promega's Cell Culture Lysis Reagent. Extracts were analyzed as described above for the in vitro work. Drinking water was supplemented with 5 mg/mL Doxycycline and 0.1% sodium saccharine for 6 days to suppress tTA-induced activation.
###end p 59
###begin title 60
Authors' contributions
###end title 60
###begin p 61
###xml 47 56 47 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 230 238 230 238 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 272 280 272 280 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 146 161 <span type="species:ncbi:10090">transgenic mice</span>
###xml 464 479 <span type="species:ncbi:10090">transgenic mice</span>
AMG performed the updated vector construction, in vitro testing of the gene-trap tTA, preparation of transgenes, breeding and characterization of transgenic mice, 5'RACE, RT-PCR, western blotting, Southern blotting, and aided the in vivo imaging studies. AW performed the in vivo imaging for luciferase expression. CMC bred and characterized 'rescue by remobilization' for insertion 01-0032. PDL performed PCR-based methods to identify gene-trap tTA insertions in transgenic mice. KJC originally designed the gene-trap tTA system and was instrumental to upgrading its design and functionality. PBH, RSM, and DAL are not only the mentors of the above authors, but were involved in the design and execution of this manuscript.
###end p 61
###begin title 62
Supplementary Material
###end title 62
###begin title 63
Additional File 1
###end title 63
###begin p 64
###xml 0 63 0 63 <bold xmlns:xlink="http://www.w3.org/1999/xlink">T2/GT2/tTA/SVNeo clone 5'RACE sequence and gene identification </bold>
###xml 258 262 <span type="species:ncbi:7962">carp</span>
T2/GT2/tTA/SVNeo clone 5'RACE sequence and gene identification Splicing events of genes into the gene-trap tTA were identified by 5'RACE PCR and sequencing. For seven clones, the partial sequence tag demonstrates splicing into the proper branch point of the carp beta-actin splice acceptor, allowing identification of the trapped gene by the sequence of the adjoined endogenous exon sequence. These genes and their functions are described according to the ENSEMBL May 17, 2005 freeze of the NCBI m34 build.
###end p 64
###begin p 65
Click here for file
###end p 65
###begin title 66
Additional File 2
###end title 66
###begin p 67
###xml 0 31 0 31 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Germline T2/GT2/tTA insertions </bold>
###xml 148 149 148 149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 121 125 <span type="species:ncbi:10090">mice</span>
Germline T2/GT2/tTA insertions The genomic positions of thirty T2/GT2/tTA insertions identified in the offspring of seed mice from line 4563 (Table 1) are reported. Shown are the chromosome and position, along with the identification and description of known or predicted genes potentially disrupted for each insertion. This data is based on the ENSEMBL May17, 2005 freeze of the NCBI m34 build.
###end p 67
###begin p 68
Click here for file
###end p 68
###begin title 69
Additional File 3
###end title 69
###begin p 70
###xml 0 45 0 45 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Distribution of thirty T2/GT2/tTA insertions </bold>
###xml 125 126 125 126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 87 91 <span type="species:ncbi:10090">mice</span>
###xml 172 177 <span type="species:ncbi:10090">mouse</span>
###xml 221 226 <span type="species:ncbi:10090">mouse</span>
###xml 320 324 <span type="species:ncbi:10090">mice</span>
Distribution of thirty T2/GT2/tTA insertions Cloning insertions from offspring of seed mice from transgenic line 4563 (Table 1) reveals two local hopping intervals, one on mouse chromosome 1 near 45.8 Mb, and a second on mouse chromosome-9 around 66.5 Mb. By Southern blot, it was later determined that the 4563 line of mice originally obtained and segregated two independent concatemer integrations during the initial transgenesis (data not shown)
###end p 70
###begin p 71
Click here for file
###end p 71
###begin title 72
Additional File 4
###end title 72
###begin p 73
###xml 0 16 0 16 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Primer sequences</bold>
Primer sequences
###end p 73
###begin p 74
Click here for file
###end p 74
###begin title 75
Acknowledgements
###end title 75
###begin p 76
The authors would like to thank Dr. Abdul Waheed (Saint Louis University) for providing the anti-CAXII antibody in addition to all members of the Arnold and Mabel Beckman Center for Transposon Research for continuous dedication to stimulating discussion. The authors were supported by N.I.D.A. grant R01-DA014764 (AMG, DAL), N.I.H. grant T32 HD007480 (AMG), and N.I.G.M.S. grant T32 GM08347 (AW).
###end p 76
###begin article-title 77
###xml 103 108 <span type="species:ncbi:9606">human</span>
Molecular reconstruction of Sleeping Beauty, a Tc1-like transposon from fish, and its transposition in human cells
###end article-title 77
###begin article-title 78
Resident aliens: the Tc1/mariner superfamily of transposable elements
###end article-title 78
###begin article-title 79
Mammalian germ-line transgenesis by transposition
###end article-title 79
###begin article-title 80
###xml 30 35 <span type="species:ncbi:10090">mouse</span>
Transposon mutagenesis of the mouse germline
###end article-title 80
###begin article-title 81
###xml 94 98 <span type="species:ncbi:10090">mice</span>
Characterization of Sleeping Beauty transposition and its application to genetic screening in mice
###end article-title 81
###begin article-title 82
###xml 89 93 <span type="species:ncbi:10090">mice</span>
Efficient chromosomal transposition of a Tc1/mariner- like transposon Sleeping Beauty in mice
###end article-title 82
###begin article-title 83
###xml 51 55 <span type="species:ncbi:10090">mice</span>
Region-specific saturation germline mutagenesis in mice using the Sleeping Beauty transposon system
###end article-title 83
###begin article-title 84
Strategies of conditional gene expression in myocardium: an overview
###end article-title 84
###begin article-title 85
###xml 46 51 <span type="species:ncbi:10090">mouse</span>
Conditional control of gene expression in the mouse
###end article-title 85
###begin article-title 86
Making better transgenic models: conditional, temporal, and spatial approaches
###end article-title 86
###begin article-title 87
###xml 15 25 <span type="species:ncbi:7227">Drosophila</span>
GAL4 system in Drosophila: a fly geneticist's Swiss army knife
###end article-title 87
###begin article-title 88
Tight control of gene expression in mammalian cells by tetracycline-responsive promoters
###end article-title 88
###begin article-title 89
Transposon vectors for gene-trap insertional mutagenesis in vertebrates
###end article-title 89
###begin article-title 90
Structure-function analysis of the inverted terminal repeats of the sleeping beauty transposon
###end article-title 90
###begin article-title 91
Transcriptional activation by tetracyclines in mammalian cells
###end article-title 91
###begin article-title 92
###xml 62 67 <span type="species:ncbi:10090">mouse</span>
Transposition and gene disruption in the male germline of the mouse
###end article-title 92
###begin article-title 93
###xml 52 57 <span type="species:ncbi:10090">mouse</span>
Regulated transposition of a fish transposon in the mouse germ line
###end article-title 93
###begin article-title 94
Deletion of a DNA polymerase beta gene segment in T cells using cell type-specific gene targeting
###end article-title 94
###begin article-title 95
###xml 47 62 <span type="species:ncbi:10090">transgenic mice</span>
Tissue- and site-specific DNA recombination in transgenic mice
###end article-title 95
###begin article-title 96
Manipulation of transgenes by site-specific recombination: use of Cre recombinase
###end article-title 96
###begin article-title 97
###xml 89 94 <span type="species:ncbi:10090">mouse</span>
Cancer gene discovery in solid tumours using transposon-based somatic mutagenesis in the mouse
###end article-title 97
###begin article-title 98
###xml 82 87 <span type="species:ncbi:10090">mouse</span>
Expression of hypoxia-inducible, membrane-bound carbonic anhydrase isozyme XII in mouse tissues
###end article-title 98
###begin article-title 99
###xml 67 72 <span type="species:ncbi:10090">mouse</span>
Transmembrane carbonic anhydrase isozymes IX and XII in the female mouse reproductive organs
###end article-title 99
###begin article-title 100
###xml 84 99 <span type="species:ncbi:10090">transgenic mice</span>
Doxycycline-mediated quantitative and tissue-specific control of gene expression in transgenic mice
###end article-title 100
###begin article-title 101
###xml 70 74 <span type="species:ncbi:10090">mice</span>
Long-term, noninvasive imaging of regulated gene expression in living mice
###end article-title 101
###begin article-title 102
###xml 50 55 <span type="species:ncbi:9031">chick</span>
###xml 60 65 <span type="species:ncbi:10090">mouse</span>
Differential expression of beta3 integrin gene in chick and mouse cranial neural crest cells
###end article-title 102
###begin article-title 103
Microtubule actin crosslinking factor 1b: a novel plakin that localizes to the Golgi complex
###end article-title 103
###begin article-title 104
Tet-system for the regulation of gene expression during embryonic development
###end article-title 104
###begin article-title 105
###xml 39 54 <span type="species:ncbi:10090">transgenic mice</span>
Temporal control of gene expression in transgenic mice by a tetracycline-responsive promoter
###end article-title 105
###begin article-title 106
Conspiracy of silence among repeated transgenes
###end article-title 106
###begin article-title 107
Identification and validation of PDGF transcriptional targets by microarray-coupled gene-trap mutagenesis
###end article-title 107
###begin article-title 108
An efficient gene-trap method using poly A trap vectors and characterization of gene-trap events
###end article-title 108
###begin article-title 109
###xml 24 29 <span type="species:ncbi:10090">mouse</span>
###xml 153 157 <span type="species:ncbi:10090">mice</span>
A gene trap approach in mouse embryonic stem cells: the lacZ reported is activated by splicing, reflects endogenous gene expression, and is mutagenic in mice
###end article-title 109
###begin article-title 110
###xml 97 101 <span type="species:ncbi:10090">mice</span>
Gene trapping methods for the identification and functional analysis of cell surface proteins in mice
###end article-title 110
###begin article-title 111
A 9-nt segment of a cellular mRNA can function as an internal ribosome entry site (IRES) and when present in linked multiple copies greatly enhances IRES activity
###end article-title 111
###begin article-title 112
###xml 32 42 <span type="species:ncbi:7227">Drosophila</span>
A screen for genes expressed in Drosophila imaginal discs
###end article-title 112
###begin article-title 113
Targeted expression of tetanus toxin: a new tool to study the neurobiology of behavior
###end article-title 113
###begin article-title 114
In vivo imaging of activated estrogen receptors in utero by estrogens and bisphenol A
###end article-title 114
###begin article-title 115
In utero delivery of adeno-associated viral vectors: intraperitoneal gene transfer produces long-term expression
###end article-title 115
###begin article-title 116
Co-regulation of two gene activities by tetracycline via a bidirectional promoter
###end article-title 116
###begin article-title 117
###xml 116 121 <span type="species:ncbi:10090">mouse</span>
A GFP-equipped bidirectional expression module well suited for monitoring tetracycline-regulated gene expression in mouse
###end article-title 117
###begin article-title 118
Expression of green fluorescent protein in oligodendrocytes in a time- and level-controllable fashion with a tetracycline-regulated system
###end article-title 118
###begin article-title 119
Inducible gene knockouts in the small intestinal and colonic epithelium
###end article-title 119
###begin article-title 120
###xml 28 33 <span type="species:ncbi:9606">human</span>
Regulated expression of the human CFTR gene in epithelial cells
###end article-title 120
###begin article-title 121
###xml 59 64 <span type="species:ncbi:10090">mouse</span>
Sequences responsible for transcription termination of the mouse gastrin gene
###end article-title 121
###begin article-title 122
A genome-wide, end-sequenced 129Sv BAC library resource for targeting vector construction
###end article-title 122
###begin article-title 123
Dynamic gene expression after systemic delivery of plasmid DNA as determined by in vivo bioluminescence imaging
###end article-title 123
###begin title 124
Figures and Tables
###end title 124
###begin p 125
###xml 32 41 32 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 0 51 0 51 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Gene-trap tTA vector design and <italic>in vitro </italic>testing A)</bold>
###xml 249 250 249 250 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 249 250 249 250 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>B</italic></bold>
###xml 252 255 252 255 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bam</italic>
###xml 264 269 264 269 <bold xmlns:xlink="http://www.w3.org/1999/xlink">) B) </bold>
###xml 706 709 706 709 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C) </bold>
###xml 878 880 878 880 <sup xmlns:xlink="http://www.w3.org/1999/xlink">R </sup>
###xml 928 931 928 931 <bold xmlns:xlink="http://www.w3.org/1999/xlink">D) </bold>
###xml 978 980 978 980 <sup xmlns:xlink="http://www.w3.org/1999/xlink">R </sup>
###xml 1068 1069 1068 1069 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C</bold>
###xml 1071 1074 1071 1074 <bold xmlns:xlink="http://www.w3.org/1999/xlink">E) </bold>
###xml 1106 1108 1106 1108 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C </bold>
###xml 544 548 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
Gene-trap tTA vector design and in vitro testing A). The T2/GT2/tTA and T2/GT3/tTA vectors. The 'GT2' version is capable of mutating genes in one orientation while the 'GT3' version can mutate genes in both orientations upon insertion into a gene. (B- BamHI sites ) B) Compared to normal expression (left), when the T2/GT2/tTA SB transposon-based gene-trap vector inserts into a gene in the direction of transcription (right), endogenous splicing incorporates the IRES and tTA sequences and the bicistronic mRNA is prematurely truncated at the SV40 late polyadenylation site. The bicistronic mRNA allows cap-independent translation of the tTA molecule in addition to any peptide encoded by upstream exons. C) A stable, TRE-regulated luciferase cell line was created to test the T2/GT2/tTA/SVNeo transposon vector. After co-transfection with a plasmid source of transposase, G418R clones were individually expanded for analysis. D) Individual luciferase expression levels of G418R clone cell extracts from twelve control (pT2/SVNeo) and fifty gene-trap tTA clones from C. E) Incubation of three clones from C in media supplemented with 2 mM doxycycline results in 10- to 100-fold reduction of luciferase expression.
###end p 125
###begin p 126
###xml 0 47 0 47 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Phenotypic rescue by transposon mobilization A)</bold>
###xml 129 138 129 138 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Slc25a22 </italic>
###xml 178 184 178 184 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al </italic>
###xml 306 309 306 309 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B) </bold>
###xml 415 432 415 432 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S2">Additional file 2</xref>
###xml 123 128 <span type="species:ncbi:10090">mouse</span>
Phenotypic rescue by transposon mobilization A). Breeding scheme to remobilize a transposon insertion, 01-0032, out of the mouse Slc25a22 gene as previously reported by Carlson, et al . (2003). Animals for both the single-copy transposon insertion 01-0032 and the CAGGS-SB10 transposase were intercrossed. B) Germline single-copy remobilization rates of the independently generated insertions 01-0032 and 02A-0016 (Additional file 2) were detected by analyzing the donor site for evidence of a transposon footprint by sequencing (data not shown).
###end p 126
###begin p 127
###xml 0 54 0 54 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Molecular characterization of gene-trap tTAfunction A)</bold>
###xml 89 95 89 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Car12 </italic>
###xml 136 155 136 155 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ENSMUSG00000066992 </italic>
###xml 337 340 337 340 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B) </bold>
###xml 360 366 360 366 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Car12 </italic>
###xml 376 381 376 381 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Car12</italic>
###xml 466 468 466 468 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Kd</bold>
###xml 477 479 477 479 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Br</bold>
###xml 487 489 487 489 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Lv</bold>
###xml 497 499 497 499 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Te</bold>
###xml 508 510 508 510 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Ad</bold>
###xml 520 522 520 522 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Co</bold>
###xml 529 531 529 531 <bold xmlns:xlink="http://www.w3.org/1999/xlink">SI</bold>
###xml 549 551 549 551 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Ov</bold>
###xml 559 561 559 561 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Mu</bold>
###xml 570 572 570 572 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Ht</bold>
###xml 579 582 579 582 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C) </bold>
###xml 743 746 743 746 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C) </bold>
###xml 83 88 <span type="species:ncbi:10090">mouse</span>
###xml 130 135 <span type="species:ncbi:10090">mouse</span>
Molecular characterization of gene-trap tTAfunction A). Insertions 02A-0001 in the mouse Car12 gene and insertion 02A-0002 in the mouse ENSMUSG00000066992 gene. Genes are shown in the orientation of transcription from left to right, vertical lines are exons, along with the position and orientation of the T2/GT2/tTA insertion (arrows). B) RT-PCR detection of Car12 (top) and Car12-IRES-tTA chimeric (bottom) transcription in wild type and 02A-0001 carrier tissues. Kd-kidney, Br-brain, Lv-liver, Te-testes, Ad-adipose, Co-colon,SI-small intestine, Ov-ovary, Mu-muscle, Ht-heart C) RT-PCR analysis of gene disruption in tissues from wild type (+/+), heterozygous (+/ins), and homozygous (ins/ins) carriers of insertions 02A-0001 and 02A-0002. C) Western analysis of CA-XII expression in a wild type, heterozygous and homozygous carrier of insertion 02A-0001. Cross-reaction of the CA-XII antibody with other isoforms serves as a loading control (arrowhead).
###end p 127
###begin p 128
###xml 89 97 89 97 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 0 99 0 99 <bold xmlns:xlink="http://www.w3.org/1999/xlink">T2/GT3/tTA gene disruptions and tissue-specific activation of a tet-responsive transgene <italic>in vivo </italic>A)</bold>
###xml 362 365 362 365 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B) </bold>
###xml 128 133 <span type="species:ncbi:10090">mouse</span>
###xml 507 511 <span type="species:ncbi:10090">mice</span>
T2/GT3/tTA gene disruptions and tissue-specific activation of a tet-responsive transgene in vivo A). T2/GT3/tTA insertions into mouse genes not linked to the original donor site. The genes are shown in the orientation of transcription with vertical lines as exons (from left to right) with the position and orientation of the IRES-tTA trapping cassette (arrow). B) Luciferase assays performed on individual tissues from four independent 02A-0002; Tg(tetL)1Bjd/J doubly transgenic and control Tg(tetL)1Bjd/J mice.
###end p 128
###begin p 129
###xml 0 8 0 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In vivo </italic>
###xml 0 75 0 75 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>In vivo </italic>imaging of gene-trap tTAactivation of a tet-responsive transgene A)</bold>
###xml 343 344 343 344 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 346 349 346 349 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B) </bold>
###xml 368 374 368 374 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MacF1 </italic>
###xml 412 418 412 418 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gapdh </italic>
###xml 460 462 460 462 <bold xmlns:xlink="http://www.w3.org/1999/xlink">ES</bold>
###xml 485 487 485 487 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Lv</bold>
###xml 495 497 495 497 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Kd</bold>
###xml 506 508 506 508 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Br</bold>
###xml 516 518 516 518 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Lu</bold>
###xml 525 527 525 527 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Ht</bold>
###xml 535 537 535 537 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Sp</bold>
###xml 546 548 546 548 <bold xmlns:xlink="http://www.w3.org/1999/xlink">St</bold>
###xml 558 560 558 560 <bold xmlns:xlink="http://www.w3.org/1999/xlink">BM</bold>
###xml 574 576 574 576 <bold xmlns:xlink="http://www.w3.org/1999/xlink">SI</bold>
###xml 594 596 594 596 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Co</bold>
###xml 604 606 604 606 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Ad</bold>
###xml 616 618 616 618 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Mu</bold>
###xml 627 629 627 629 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Ov</bold>
###xml 647 649 647 649 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Th</bold>
###xml 657 660 657 660 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C) </bold>
###xml 691 693 691 693 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A </bold>
###xml 697 699 697 699 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B </bold>
###xml 776 779 776 779 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bam</italic>
###xml 998 1001 998 1001 <bold xmlns:xlink="http://www.w3.org/1999/xlink">D) </bold>
###xml 1130 1132 1130 1132 <sup xmlns:xlink="http://www.w3.org/1999/xlink">4 </sup>
###xml 1139 1141 1139 1141 <sup xmlns:xlink="http://www.w3.org/1999/xlink">8 </sup>
###xml 1158 1160 1158 1160 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
###xml 1174 1177 1174 1177 <bold xmlns:xlink="http://www.w3.org/1999/xlink">E) </bold>
###xml 1191 1199 1191 1199 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 1288 1289 1288 1289 <bold xmlns:xlink="http://www.w3.org/1999/xlink">D</bold>
###xml 158 163 <span type="species:ncbi:10090">mouse</span>
###xml 681 685 <span type="species:ncbi:10090">mice</span>
###xml 1037 1042 <span type="species:ncbi:10090">mouse</span>
###xml 1048 1052 <span type="species:ncbi:10090">Mice</span>
###xml 1278 1282 <span type="species:ncbi:10090">mice</span>
In vivo imaging of gene-trap tTAactivation of a tet-responsive transgene A). Luciferase emission pattern seen in a 03A-0241; Tg(tetL)1Bjd/J doubly transgenic mouse (936) as imaged by an intensified charge-coupled device (CCD) camera. Ventral and dorsal aspects are shown. The intensity of luciferase expression is compared in photons/second/cm2. B) RT-PCR analysis of MacF1 expression in multiple adult tissues, Gapdh was used as a control for sample quality. ES-embryonic stem cells, Lv-liver, Kd-kidney, Br-brain, Lu-lung, Ht-heart, Sp-spleen, St-stomach, BM-bone marrow, SI-small intestine, Co-colon, Ad-adipose, Mu-muscle, Ov-ovary, b-testes, Th-thymus C) Southern analysis of mice from A and B (see Materials and Methods). The donor site concatemer appears as an intense BamHI fragment at 2236 base pairs (arrowhead). The detection of insertion 03A-0241 by three-primer PCR is shown below each lane. Three bands marked by arrows segregate with insertion 03A-0241 genotyping and the concatemer.D) Pattern inheritance by offspring of mouse 936. Mice were imaged and scaled to different ranges of intensity that ranged from 1x104 to 1x108 photons/second/cm2 (scale bars). E) Repression of in vivo luciferase activation after six days of treatment with doxycycline in the same mice from D.
###end p 129
###begin p 130
###xml 67 71 <span type="species:ncbi:10090">mice</span>
Mobilization of gene-trap tTA transposons in the germlines of seed mice.
###end p 130
###begin p 131
###xml 0 2 0 2 <italic xmlns:xlink="http://www.w3.org/1999/xlink">a </italic>
###xml 0 2 0 2 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>a </italic></sup>
a Transposon copy number for each transgenic line was determined by Southern blot (see Materials and Methods)
###end p 131
###begin p 132
###xml 0 2 0 2 <italic xmlns:xlink="http://www.w3.org/1999/xlink">b </italic>
###xml 0 2 0 2 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>b </italic></sup>
###xml 159 163 <span type="species:ncbi:10090">mice</span>
b The number of single-copy insertions as determined by the presence of new bands on a Southern blot after mobilization by transposase in the germline of seed mice
###end p 132
###begin p 133
###xml 0 2 0 2 <italic xmlns:xlink="http://www.w3.org/1999/xlink">c </italic>
###xml 0 2 0 2 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>c </italic></sup>
c Reported is the average hits/gemete divided by the copy number
###end p 133

